Results 131 to 140 of about 30,319,267 (183)

Corrigendum to "Isoflurane versus sevoflurane for early brain injury and expression of sphingosine kinase 1 after experimental subarachnoid hemorrhage" [Neurosci. Lett. 733 (2020) 135142]. [PDF]

Neurosci Lett
Altay O, Suzuki H, Altay BN, Calisir V, Tang J, Zhang JH.   +5 more
europepmc   +1 more source

Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis. [PDF]

Cell Mol Immunol, 2022
Lau P, Zhang G, Zhao S, Liang L, Zhang H, Zhou G, Hung MC, Chen X, Liu H.   +8 more
europepmc   +1 more source

Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters. [PDF]

Cancers (Basel), 2022
Gomez-Brouchet A, Illac C, Ledoux A, Fortin PY, de Barros S, Vabre C, Despas F, Peries S, Casaroli C, Bouvier C, Aubert S, de Pinieux G, Larousserie F, Galmiche L, Talmont F, Pitson S, Maddelein ML, Cuvillier O.   +17 more
europepmc   +1 more source

Commentary: Sphingosine-1-phosphate inhibitors are potential therapeutic targets for pulmonary arterial hypertension

Frontiers in Pharmacology, 2015
Naga P Bhavanam, Athena eFailla, Young eCho, Richard F. Lockey, Narasaiah eKolliputi   +4 more
doaj   +1 more source

Upregulated <i>BLM</i> and <i>RECQL4</i> in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisib. [PDF]

Immunotargets Ther
Chen J, Situ Y, Cai J, Liao W, Jiang D, Huang C, Zheng J, Peng L, Lin H.   +8 more
europepmc   +1 more source

The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V. [PDF]

Cell Death Discov, 2022
Sun X, Shan HJ, Yin G, Zhang XY, Huang YM, Li HJ.   +5 more
europepmc   +1 more source

Exploring anticancer activity of baicalin, naringenin, and noscapine via binding and inhibition of sphingosine kinase 1. [PDF]

3 Biotech
Shakeel I, Mohammad T, Haider S, Hussain A, AlAjmi MF, Chakrabarty A, Sohal SS, Afzal M, Hassan MI.   +8 more
europepmc   +1 more source

Design, synthesis and analysis of novel sphingosine kinase-1 inhibitors to improve oral bioavailability. [PDF]

Bioorg Med Chem Lett, 2021
Butler KJ, Castro AA, Dwyer TS, Hardwick LM, Iacino MC, Manore SG, Mays KM, McGlade CA, Hair LN, Parker EW, Smith MR, Turnow MT, Wilson MR, Woodson SR, Cotham WE, Walla MD, Hurlbert JC, Christian Grattan T.   +17 more
europepmc   +1 more source

Study on the CHJ01 antitumor activity and mechanism via targeting sphingosine kinase 1 in A549 cells. [PDF]

Pharm Sci Adv
Liu C, Gao S, Liu B, Zhang F, Mu Y, Wang F, Li Y.   +6 more
europepmc   +1 more source

Sphingosine Kinase 1 Regulates the Pulmonary Vascular Immune Response. [PDF]

Cell Biochem Biophys, 2021
Bai Y, Lockett AD, Gomes MT, Stearman RS, Machado RF.   +4 more
europepmc   +1 more source